| Application no. and date | 21724012.6 (espacenet) (Federated) (European Patent Register), 20210423 | | Patent/reg. no. and date | DK/EP 4138790, 20240131 | | Publication date | 20230301 | | Priority no. and date | GB 202006079, 20200424 | | EP pub. no. and date |
EP 4138790 20230301 | | Effective date | | | Applicant/owner | Vicore Pharma AB, Kornhamnstorg 53
111 27 Stockholm, SE | | Applicant ref. no. | VICQ/P76948EP | | Inventor | CAMBER, Ola, Kornhamnstorg 53
111 27 Stockholm, SE,
GRUDÉN, Stefan, Rimbertsv. 10 A
752 60 Uppsala, SE,
EVERAERT, Arnout, Kleimoer 4
9030 Mariakerke, BE | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 4. tv., 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/4178 (2006.01) , A61K 47/02 (2006.01) , A61K 47/10 (2017.01) , A61K 9/48 (2006.01) , A61P 11/00 (2006.01) | | Title | NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION | | Int. application no. | GB2021050994 | | Int. publication no. | WO2021214488 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
